Articles and Blogs

On Friday, December 11, the U.S. Food and Drug Administration issued the first emergency use authorization (“EUA”) for a vaccine for the prevention of coronavirus disease 2019 (“COVID-19”) caused by severe acute respiratory syndrome coronavirus 2 (“SARS-CoV-2”) in individuals 16 years of age and older. The EUA allows the Pfizer-BioNTech COVID-19 Vaccine to be... READ MORE

Since the onset of the Severe Acute Respiratory Syndrome Coronavirus 2 (“SARS-CoV-2”) pandemic in early 2020, the federal government has been working diligently through Operation Warp Speed to expedite vaccine development for the prevention of Coronavirus Disease 2019 (“COVID-19”). Given the possibility that one or more COVID-19 vaccines may become available before the new... READ MORE

The lack of medical supplies and equipment necessary to treat patients and to protect individuals and health care workers from becoming infected with and spreading COVID-19 has been a constant refrain during this pandemic. The overall supply of these essential items, ranging from ventilators to personal protective equipment (“PPE”) to prevent the spread of... READ MORE